Blend Labs Inc (BLND) is not a strong buy for a beginner, long-term investor at this time. The technical indicators are mixed, with bearish moving averages and neutral RSI, while the company's financial performance shows significant declines in revenue, net income, and EPS. The options data suggests a lack of significant bullish sentiment, and there are no strong positive catalysts or recent influential trades to support a buy decision. For a long-term investor, it may be prudent to wait for clearer signs of financial recovery or stronger market sentiment before investing.
The MACD histogram is positive and expanding, indicating mild bullish momentum. However, the RSI is neutral at 46.134, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels suggest limited upside potential in the short term, with resistance at 1.789 and support at 1.598.

The MACD shows mild bullish momentum, and the gross margin increased slightly YoY to 74.42%.
Revenue, net income, and EPS have all declined significantly YoY. Analysts have lowered price targets, and there are no significant insider or hedge fund trading trends. Additionally, the stock's technical indicators suggest limited upside in the near term.
In Q3 2025, revenue dropped by -0.74% YoY to $32.86M, net income dropped by -196.62% YoY to $7.97M, and EPS dropped by -200.00% YoY to $0.03. Gross margin increased slightly to 74.42%, up 0.55% YoY.
Barclays recently lowered the price target on BLND to 450 GBp from 460 GBp, maintaining an Equal Weight rating. This reflects a neutral to slightly bearish sentiment among analysts.